Signal Advisors Wealth’s Pfizer PFE Stock Holding History

Signal Advisors Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$284K	Sell	11,807 -2,582	-18%	-$67.5K	0.01%	543
2026 Q1	$404K	Buy	+14,389	New	+$383K	0.03%	408
2025 Q2	–	Sell	-8,826	Closed	-$224K	–	527
2025 Q1	$224K	Buy	8,826 +1,258	+17%	+$32.9K	0.02%	407
2024 Q4	$201K	Buy	7,568 +221	+3%	+$6K	0.02%	419
2024 Q3	$213K	Buy	+7,347	New	+$214K	0.03%	404
2024 Q2	–	Sell	-8,359	Closed	-$232K	–	225
2024 Q1	$232K	Buy	+8,359	New	+$232K	0.06%	270

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Signal Advisors Wealth's PFE Position: Q2 2026 in Review

Signal Advisors Wealth reduced its Pfizer (PFE) stake by 18% in Q2 2026, selling an estimated $67.5K and leaving 11,807 shares worth $284K. The position accounts for 0.01% of the portfolio, ranked #543.

Signal Advisors Wealth first reported a position in PFE in Q1 2024 and has held it in 6 quarters since. The position peaked at $404K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Signal Advisors Wealth held 11,807 shares of Pfizer worth $284K as of Q2 2026.
Signal Advisors Wealth sold 2,582 Pfizer shares in Q2 2026, an estimated $67.5K.
Pfizer made up 0.01% of Signal Advisors Wealth's portfolio in Q2 2026, its #543 holding.
Signal Advisors Wealth first reported a position in Pfizer in Q1 2024 and has held it in 6 quarters since.
Signal Advisors Wealth's Pfizer position peaked at $404K in Q1 2026.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Signal Advisors Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.